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Abstract
Background
Although Parkinson’s disease (PD) is a progressive neurodegenerative disorder character-
ized primarily by motor symptoms, PD patients, at all stages of the disease, can experience
cognitive dysfunction. However, the relationships between cognitive and motor symptoms
and specific demographic characteristics are not well defined, particularly for patients who
have progressed to requiring dopaminergic medication.
Objective
To examine relationships between motor and cognitive symptoms and various demographic
factors in mild to moderate, PD patients requiring anti-PD medication.
Methods
Cognitive function was assessed in 94 subjects with a variety of neuropsychological tests
during baseline evaluations as part of an experimental treatment study. Data were analyzed
in relation to Unified Parkinson’s Disease Rating Scale motor scores and demographic
variables.
Results
Of the UPDRS subscores analyzed, posture/balance/gait was associated with the highest
number of adverse cognitive outcomes followed by speech/facial expression, bradykinesia,
and rigidity. No associations were detected between any of the cognitive performance mea-
sures and tremor. Motor functioning assessed in the “off” condition correlated primarily with
disease duration; neuropsychological performance in general was primarily related to age.
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Conclusion
In PD patients who have advanced to requiring anti-PD therapies, there are salient associa-
tions between axial signs and cognitive performance and in particular, with different aspects
of visuospatial function suggesting involvement of similar circuits in these functions. Associ-
ations between executive functions and bradykinesia also suggest involvement similar cir-
cuits in these functions.
Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized primarily
by motor symptoms including bradykinesia, resting tremor, rigidity, and postural instability.
However, it has become increasingly apparent that PD patients, at all stages of the disease, can
experience cognitive dysfunction. Although there is heterogeneity to the clinical presentation
of cognitive impairment in PD in general [1] and particularly earlier in the disease process, the
cognitive impairment in PD often involves executive function, attention, visuospatial function
and working memory, suggesting a frontal or fronto-striatal nature to these cognitive deficits
[2,3,4,5].
Several studies have examined relationships between motor symptoms and cognitive func-
tions in PD and in general, such studies have reported that bradykinesia and rigidity are corre-
lated with at least some types of cognitive impairment while tremor is less likely to correlate
with cognitive impairment [6,7,8,9]. For example, Huber et al. [10] compared levodopa-treated
patients (Hoehn and Yahr stage 2–3) with tremor predominant disease to those with bradyki-
nesia/rigidity dominant disease and found only the latter group to exhibit memory, visuospa-
tial, and executive function deficits. Further, they found that age of onset of PD had little
influence on neuropsychological performance when overall effect of age was controlled for
[10]. However, these and similar findings are difficult to interpret since patients were tested
while medicated and the effects of dopaminergic medications on cognition are varied and may
affect individual cognitive symptoms differentially [11].
To overcome this potential problem with the interpretation of data obtained from medicat-
ed patients, other studies examining the relationship between motor symptoms and cognition
in PD have utilized newly diagnosed, drug naive (de novo) patients [12,13]. In one such study,
bradykinesia was associated with working memory and mental flexibility, whereas axial signs
were associated with episodic memory and visuospatial function [13]. These authors suggested
that slow movement and inflexible thinking may be controlled by a dopaminergic network dif-
ferent from networks involved in tremor and/or rigidity, since after controlling for age, sex,
and education, no association was found between cognitive performance and tremor and rigid-
ity [13]. However, a caveat of these studies is that cognitive deficits may be subtle in newly diag-
nosed, drug naive PD patients [14,15] and it may be difficult to relate cognitive functioning to
other variables in this population, depending in large part on what types of cognitive assess-
ments are performed and how sensitive they are to detecting subtle cognitive deficits in
this population.
Although there are obvious merits to examining the relationship between cognitive and
motor symptoms in de novo PD patients without having to account for the potential compli-
cating factor of medication effects, it is also important to examine these relationships in more
advanced patients who require medication as the relationship between cognitive and motor
symptoms may change as the disease progresses. The purpose of the current study was to
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examine the relationship between motor and cognitive symptoms and various demographic
factors in mild to moderate, PD patients requiring anti-PD medication and examined in a prac-
tically defined off period.
Materials and Methods
Participants and Ethics Statement
These data were collected during baseline assessments performed as part of a study examining
long-term effects of GM1 ganglioside treatment on PD (ClinicalTrials.gov NCT00037830).
The study was approved by the Division of Human Subjects Protection at Thomas Jefferson
University and written informed consent was obtained from all subjects prior to enrollment.
Subjects were men or women between 39 and 85 years of age with a diagnosis of idiopathic PD
consistent with the UK PD Society brain bank PD diagnostic criteria. Inclusion criteria includ-
ed “off” Unified Parkinson’s Disease Rating Scale (UPDRS) motor score between 10 and 40,
“off” Hoehn and Yahr staging of 1.0 to 3.0, Mini Mental State Exam (MMSE) score 25, and
Beck Depression Inventory (BDI-II) score 10.
Procedures and Data Collection
All subjects were assessed while in a practically defined “off” period prior to taking that day's
first dose of anti-PD medication and at least 12 h after the last dose of levodopa (or 24 h after
the last dose of dopamine agonist). Pre-morbid full scale IQ (FS IQ) was estimated using the
National Adult Reading Test (NART). Motor function was assessed by two independent ob-
servers, using the UPDRS part III (motor score). The motor score used in the analysis was the
average score from the two observers. Inter-rater reliability was assessed using Pearson linear
correlation coefficient for each pair of raters and inter-rater reliability was high (median corre-
lation coefficient was 0.94 for UPDRS motor scores). Additionally, a rigidity sum was comput-
ed as the total of UPDRS items 22a-e; a bradykinesia sum was computed as the total of UPDRS
item numbers 23a-b, 24a-b, 25a-b, 26a-b, and 31; an axial sum (posture/balance/gait) was com-
puted as the total of UPDRS item numbers 27–30; a tremor sum was computed as the total of
UPDRS item numbers 20a-e and 21a-b; a speech and facial expression sum was computed as
the total of UPDRS item numbers 18 and 19.
The following tests were used to assess neuropsychological functions:
Brief Test of Attention (BTA). assessed auditory attention and requires no motor re-
sponse, making it useful for assessing attentional/working memory deficits in subjects with
motor/dexterity impairments. The subject listens to progressively longer series of lists contain-
ing letters and numbers on an audio tape and after each list is heard, the subject must report ei-
ther the number of letters or numbers that he or she heard. The total number of correct
responses (out of a maximum score of 20) was recorded.
Controlled Oral Word Association Test (COWAT). assessed verbal fluency or the spon-
taneous production of words beginning with a given letter of the alphabet (letters F, A, S were
used) within a limited time period (60 secs.). The total number of words produced (adjusted
for education) was recorded.
Wisconsin Card Sorting Test (WCST). assessed set shifting and cognitive flexibility (ex-
ecutive function). A computerized version of the WCST was used. On this test, a stimulus card
is presented on the lower portion of the computer screen and the subject is asked to match that
card to one of the four cards on the upper portion of the screen. The subject is not told how to
make the match but the computer provides feedback as to whether the match is right or wrong.
Number of perseverative errors; number of nonperseverative errors; number of categories com-
pleted; number of trials to complete first category were recorded.
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Ruff-Light Trail Learning Test (RULIT). assessed visuospatial learning and memory.
This test does not require good motor control or drawing skills and is designed to minimize or
eliminate verbal mediation for successful task completion. Subjects are presented with a stimu-
lus card that contains a complex configuration of circles that are interconnected by lines. The
subject begins at the START circle and uses an index finger to trace a line connecting the circles
from the START to the END. At each circle (or step) along the trail, there are three to five
choices for the next step, but only one choice is correct. The subject is given immediate feed-
back as to whether their choice was correct, and the subject keeps making choices until the cor-
rect choice is made. This process continues through the 15-step trail. Successive trials are
administered until the trail is recalled without an error on two consecutive trials. Immediate
memory is analyzed by the number of steps correctly completed in Trial 2. Learning is analyzed
by the number of trials needed to master the task (total correct)). Long-term (delayed) memory
is assessed by having the subject retrace the trail after a 60-minute delay and the number of
steps correctly completed was recorded.
Conditional Associative Learning Task. assessed learning of arbitrary associations be-
tween a set of stimuli and a set of responses. The conditional associative-learning task required
subjects to learn, with immediate correction, spatial locations associated with specific stimuli.
Four disks and four blank cards are placed are placed in front of the subject. The subject is in-
structed that each card is associated with only one of these disks and that they need to learn the
associations. The experimenter points to a disk and the subject must point to a card and the
subject is provided feedback as to whether they have made a correct association. There is a
maximum of 3 errors allowed per trial. If 3 errors are made, the administrator shows the sub-
ject the correct response. The number of trials to criterion (out of a maximal score of 68)
were recorded.
Stockings of Cambridge. This test of fronto-executive function assesses planning and
problem solving ability and is part of the Cambridge Neuropsychological Test Automated Bat-
tery (CANTAB), a computer/touch screen-based cognitive assessment system. In the “plan and
move” condition, subjects had to move three colored circles in the lower half of the screen to
match a given pattern in the upper half of the screen. The difficulty of the task increased as the
number of moves needed to complete the task increased from two to five. Subjects are in-
structed to wait to begin moving balls until they have planned their moves. In a second condi-
tion that controls for motor performance, the “follow” condition, is administered. Subjects are
simply required to follow moves made by the computer. By subtracting response times in the
“follow” condition from those in the “plan and move” condition, it is possible to separately
measure planning and movement times [16]. The number of moves to solution of the problem,
the proportion of problems solved in minimum number of moves, the initial thinking time,
and the subsequent thinking time were recorded.
Spatial Working Memory. This task, also from the CANTAB battery, is a self-ordered
spatial search task in which the subject must search for (and find) blue tokens that are hidden
inside of colored squares on the screen. The number of items to be searched increases as the
task progresses from 2 items to 8 items. Once a blue token had been found within a particular
box, that box would not contain another token, as every box was used only once. The test be-
gins with a number of colored boxes shown on the screen and the subject must touch the boxes
using a process of elimination, to find one blue ‘token’ in each of the boxes and use them to fill
up an empty column on the right hand side of the screen. The number of boxes is gradually in-
creased, until it is necessary to search a total of eight boxes. The color and position of the boxes
used are changed from trial to trial to discourage the use of stereotyped search strategies.: For
sets of length 4, 6 and 8 boxes, the number of between errors (a subject returns to open a box in
which a token has already been found) were assessed.
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Statistical Analysis
Univariate analyses of motor symptoms (M) as measured by the UPDRS part III (motor)
scores, cognition (C) as measured by cognitive assessment instruments described above, and
demographic characteristics (D) were performed. These included summarizing categorical var-
iables with frequencies and percentages and continuous variables with means, standard devia-
tions, medians, and the interquartile ranges. The distribution of continuous variables was
checked using box plots, histograms, and normal probability plots. For demographic variables,
comparisons were made between treatment groups using a two-sample t-test with means for
continuous variables and using a Chi-square test with percentages for categorical variables. An
exact test was used when cell counts were too small for the Chi-square test to be valid. In order
to explore relationships between Motor (M) symptoms, Cognition (C), and Demographic (D)
variables, Pearson or Spearman correlation coefficients were calculated for each pair of vari-
ables. A p-value less than 0.05 was taken to indicate a statistically significant relationship be-
tween the corresponding pair of variables interrogated.
Results
Table 1 shows the demographic characteristics of the sample population (N = 94). This group
of PD patients generally had relatively short duration of disease (average 3.0 ± 2.7 years), did
not have dementia (based on MMSE criteria), did not have clinical depression (based on
BDI-II scores) and were highly educated (average 16.4 ± 3.1 years of education). Relationships
between motor symptoms (assessed during a practically defined off period) and demographic
features were explored and results showed that all UPDRS subscores (i.e., bradykinesia,
Table 1. Subject Demographics and Baseline Characteristics.
PD Subjects (n = 94)
Age (years) Mean (SD) 59.3 (9.2)
Gender: n (%) Male 72 (76.6)
Female 22 (23.4)
Disease duration (years) Mean (SD) 3.0 (2.7)
Median (Range) 2.5 (0.4–14.3)
Functional Parameters
MMSE score 28.7 (1.2)
BDI-II score 4.9 (3.9)
Estimated FS IQ 111.6 (9.8)
Education (years) 16.4 (3.1)
Total UPDRS score (Off) 29.8 (10.3)
UPDRS Motor score (Off) 20.4 (6.8)
UPDRS ADL score (Off) 8.9 (4.3)
UPDRS Mentation score (Off) 0.9 (1.0)
Medication Usage
Levodopa (# of subjects (percent)) 46 (48.9)
Dopamine Agonist* (# of subjects (percent)) 65 (69.1)
Selegiline (# of subjects (percent)) 15 (39.5)
Other (# of subjects (percent))^ 2 (5.2)
Data presented as mean ± SD, unless otherwise noted.
*Dopamine agonists included pramipexole, ropinirole, pergolide and bromocriptine.
^Other medications included amantadine, trihexyphenidyl, and benztropine.
doi:10.1371/journal.pone.0123231.t001
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posture/balance/gait, speech/facial expression, tremor) with the exception of rigidity were sig-
nificantly positively correlated with disease duration (Table 2). With the exception of posture/
balance/gait, none of the UPDRS subscores were correlated with age at diagnosis and with the
exception of rigidity, none of the UPDRS subscores were correlated with MMSE score. None of
the UPDRS motor subscores were correlated with years of education, estimated full scale IQ or
BDI-II score (Table 2).
Relationships between performance on neuropsychological tests and demographic variables
(Table 3) and performance on neuropsychological tests and UPDRS components (Table 4)
Table 2. Correlations Between Off-Period UPDRS Scores and Demographics [r (p value)].
Bradykinesia Rigidity Tremor Speech/Facial Expression Posture/Balance/Gait
Age 0.05 (0.62) 0.04 (0.70) 0.01 (0.90) 0.20 (0.05) 0.28 (< 0.01)
Disease duration 0.36 (< 0.01) 0.09 (0.39) 0.29 (< 0.01) 0.23 (0.03) 0.28 (< 0.01)
MMSE score 0.25 (0.02) -0.31 (< 0.01) 0.07 (0.49) 0.02 (0.86) -0.09 (0.37)
BDI-II score -0.01 (0.92) 0.08 (0.44) -0.05 (0.65) 0.01 (0.89) 0.13 (0.22)
Estimated FS IQ -0.08 (0.43) 0.01 (0.96) 0.12 (0.25) -0.08 (0.47) -0.14 (0.19)
Education -0.15 (0.14) -0.06 (0.56) -0.07 (0.51) -0.04 (0.73) -0.10 (0.33)
Statistically signiﬁcant relationships are shown in bold font.
doi:10.1371/journal.pone.0123231.t002
Table 3. Correlations Between Neuropsychological Performance and Demographic Variables [r (p value)].
Age Disease
Duration
MMSE score BDI-II
score
Estimated FS
IQ
Education
BTA (number correct responses) -0.30
(< 0.01)
-0.13 (0.20) 0.30 (< 0.01) -0.07 (0.48) 0.30 (< 0.01) 0.14 (0.19)
COWAT (number of words produced) -0.07 (0.53) 0.14 (0.19) 0.31 (< 0.01) -0.14 (0.17) 0.26 (0.01) 0.08 (0.47)
RULIT (learning: total number correct) -0.46
(< 0.01)
-0.18 (0.09) 0.22 (0.03) -0.07 (0.48) -0.04 (0.68) 0.14 (0.19)
RULIT (immed. memory: number correct) -0.33
(< 0.01)
-0.17 (0.11) 0.03 (0.77) -0.23 (0.03) 0.10 (0.35) 0.20 (0.06)
RULIT (delayed memory: number correct) -0.39
(< 0.01)
-0.17 (0.10) 0.16 (0.13) -0.07 (0.51) 0.00 (0.98) 0.15 (0.15)
CAL (trials to criterion) 0.22 (0.04) 0.18 (0.08) -0.13 (0.22) 0.04 (0.67) -0.05 (0.62) -0.12 (0.24)
SOC (5 move problems: initial thinking time) -0.05 (0.61) -0.16 (0.12) -0.00 (0.96) 0.00 (0.99) 0.10 (0.34) 0.15 (0.14)
SOC (5 move problems: subsequent thinking
time)
0.25 (0.02) -0.02 (0.86) -0.13 (0.20) -0.14 (0.17) -0.03 (0.75) -0.14 (0.17)
SOC (number solved in minimum moves) -0.19 (0.06) 0.04 (0.74) 0.15 (0.15) 0.07 (0.52) -0.07 (0.53) 0.21 (0.04)
SOC (number of moves to solve problem) 0.14 (0.19) -0.13 (0.23) 0.04 (0.74) -0.07 (0.49) -0.04 (0.69) -0.22 (0.03)
WCST (number categories completed) -0.21 (0.04) -0.001 (0.99) 0.28 (< 0.01) 0.03 (0.75) -0.13 (0.22) 0.25 (0.01)
WCST (trials to complete ﬁrst category) -0.14 (0.18) -0.001 (0.99) -0.43
(< 0.01)
0.02 (0.88) 0.18 (0.09) -0.12 (0.24)
WCST (number of perseverative errors) 0.28 (< 0.01) 0.02 (0.84) -0.37
(< 0.01)
-0.03 (0.76) 0.22 (0.03) -0.27
(< 0.01)
WCST (number of nonperseverative errors) 0.10 (0.35) 0.05 (0.64) -0.15 (0.16) -0.07 (0.51) -0.02 (0.83) -0.25 (0.01)
SWM (between search errors 4 boxes) 0.36 (< 0.01) -0.04 (0.74) -0.33
(< 0.01)
-0.08 (0.43) -0.03 (0.76) -0.05 (0.63)
SWM (between search errors 6 boxes) 0.28 (<0.01) 0.21 (0.05) -0.43 (<0.01) 0.09 (0.41) -0.05 (0.65) -0.16 (0.14)
SWM (between search errors 8 boxes) 0.38 (<0.01) 0.11 (0.29) -0.14 (0.18) -0.03 (0.75) 0.04 (0.69) -0.11 (0.31)
BTA = Brief Test of Attention; RULIT = Ruff-Light Trail Learning Test; CAL = Conditional Associative Learning Test; SOC = Stockings of Cambridge
WCST = Wisconsin Card Sorting Test; SWM = Spatial Working Memory Test. Statistically signiﬁcant relationships are shown in bold font.
doi:10.1371/journal.pone.0123231.t003
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were examined. Auditory attention, assessed with the BTA (number of correct responses), was
correlated with MMSE score and FS IQ and negatively correlated with age. Verbal fluency, as-
sessed by performance on the COWAT, was correlated only with MMSE score and FSIQ. Vi-
suospatial learning and memory, as assessed by the RULIT, showed visuospatial learning
ability to be positively correlated with MMSE score and negatively correlated with age Immedi-
ate and delayed visuospatial memory performance were both negatively correlated with age
and immediate memory was also negatively correlated with BDI-II score. Planning and prob-
lem solving ability showed relationships with age and education; relationships between cogni-
tive flexibility and age, MMSE score, and education were detected; spatial working memory
performance (number of errors made) was correlated with age (i.e., worse performance with
increasing age).
Performance on the COWAT was not correlated with any UPDRS measures. Brief Test of
Attention performance was negatively correlated with bradykinesia, posture/balance/gait/, and
rigidity. Conditional associative learning ability (trials to criterion) was correlated only with
bradykinesia (i.e., more trials to criterion (worse performance) correlated with higher (worse)
bradykinesia scores. Visuospatial learning (RULIT, number correct responses) was negatively
correlated with bradykinesia, speech/facial expression, and posture/balance/gait. Immediate vi-
suospatial memory was negatively associated with posture/balance/gait and speech/facial ex-
pression while delayed visuospatial memory was also negatively correlated with bradykinesia.
Planning and problem solving ability showed minimal relationships with motor function. The
number of categories completed on the WCST was negatively correlated with all UPDRS sub-
scores except tremor. The number of errors made during performance of the spatial working
Table 4. Correlations Between Neuropsychological Performance and Off UPDRSMotor Scores [r (p value)].
Bradykinesia Rigidity Tremor Speech/Facial
Expression
Posture/Balance/
Gait
BTA (number correct responses) -0.27 (< 0.01) -0.22 (0.04) -0.06 (0.57) -0.20 (0.05) -0.32 (< 0.01)
COWAT (number of words produced) -0.14 (0.19) -0.19 (0.06) 0.12 (0.25) -0.14 (0.19) -0.11 (0.30)
RULIT (learning: total number correct) -0.22 (0.04) -0.10 (0.36) 0.03 (0.75) -0.28 (< 0.01) -0.33 (< 0.01)
RULIT (immed. memory: number correct) -0.18 (0.08) -0.1 (0.32) 0.0496
(0.64)
-0.28 (< 0.01) -0.26 (0.01)
RULIT (delayed memory: number correct) -0.28 (< 0.01) -0.18 (0.08) -0.12 (0.27) -0.22 (0.03) -0.34 (< 0.01)
CAL (trials to criterion) 0.27 (<0.01) 0.18 (0.08) 0.03 (0.78) 0.05 (0.62) 0.39 (< 0.01)
SOC (5 move problems: initial thinking time) 0.14 (0.20) -0.00 (0.99) -0.07 (0.54) -0.03 (0.78) 0.023 (0.80)
SOC (5 move problems: subsequent thinking
time)
0.17 (0.11) 0.21 (0.05) -0.00 (0.95) 0.07 (0.50) 0.29 (< 0.01)
SOC (number solved in minimum moves) -0.02 (0.85) -0.13 (0.20) -0.01 (0.92) -0.31 (< 0.01) -0.28 (< 0.01)
SOC (number of moves to solve problem) 0.02 (0.87) 0.09 (0.41) 0.09 (0.37) 0.16 (0.12) 0.20 (0.05)
WCST (number categories completed) -0.29 (< 0.01) -0.36
(< 0.01)
0.06 (0.59) -0.31 (< 0.01) -0.24 (0.02)
WCST (trials to complete ﬁrst category) 0.20 (0.06) 0.42 (< 0.01) 0.03 (0.77) 0.15 (0.14) 0.19 (0.07)
WCST (number of perseverative errors) 0.19 (0.07) 0.38 (< 0.01) -0.07 (0.53) 0.27 (< 0.01) 0.18 (0.08)
WCST (number of nonperseverative errors) 0.28 (< 0.01) 0.24 (0.02) -0.03 (0.76) 0.20 (0.06) 0.25 (0.02)
SWM (between search errors 4 boxes) 0.24 (0.02) 0.13 (0.21) -0.11 (0.31) 0.18 (0.09) 0.35 (< 0.01)
SWM (between search errors 6 boxes) 0.33(< 0.01) 0.20 (0.06) -0.05 (0.63) 0.33 (< 0.01) 0.46 (<0.01)
SWM (between search errors 8 boxes) 0.17 (0.10) 0.16 (0.12) -0.15 (0.16) 0.32 (< 0.01) 0.41 (<0.01)
BTA = Brief Test of Attention; RULIT = Ruff-Light Trail Learning Test; CAL = Conditional Associative Learning Test; SOC = Stockings of Cambridge
WCST = Wisconsin Card Sorting Test; SWM = Spatial Working Memory Test. Statistically signiﬁcant relationships are shown in bold font.
doi:10.1371/journal.pone.0123231.t004
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memory task at all levels of task difficulty were primarily correlated with posture/balance/gait
(i.e., worse performance associated with worse pasture/balance/gait scores). The relationships
between neuropsychological test performance (correlation coefficients) and “off” UPDRS
motor scores are shown in the heat map in Fig 1.
Discussion
Non-motor aspects of PD have received increasing attention recently and in particular, it is ap-
preciated that cognitive changes are relatively common in non-demented PD patients [17]. Al-
though the relationships between motor dysfunction and cognition have been investigated
previously in PD patients, most studies have examined these relationships in newly diagnosed,
drug naïve patients [13] or in more advanced patients in the medicated state, with neuropsy-
chological testing performed in the “on” condition [6]. In the current study, patients requiring
anti-PD medication were studied, neuropsychological testing was performed in a practically
defined “off” condition, and motor function was assessed in an “off” condition.
For the most part, motor function assessed in the “off” condition correlated primarily with
disease duration. Neuropsychological performance primarily was related to age, MMSE score,
or education, with disease duration, BDI-II score or FS IQ having little relationship to neuro-
psychological test results. When the relationships between neuropsychological performance
and motor function were examined, it is interesting that tremor was mostly unrelated to neuro-
psychological outcomes, similar to what has been noted in other studies that examined an earli-
er PD population [13]. Also, in newly diagnosed, drug naïve PD patients, bradykinesia was
negatively associated with tests considered to have executive demands, such as the WCST (cat-
egories completed) [13]. In the present study, bradykinesia was also negatively associated with
the number of WCST categories completed, reflecting a problem with cognitive flexibility.
Of the UPDRS subscores analyzed, posture/balance/gait was associated with the highest
number of adverse cognitive outcomes followed by speech/facial expression, bradykinesia, and
rigidity. The relationships between cognitive outcomes and posture/balance/gait scores support
the observations that PD patients with a posture instability gait difficulty (PIGD) subtype may
have accelerated cognitive decline and an increased risk for developing dementia [18].
No associations were detected between any of the cognitive performance measures and
tremor. This lack of association between tremor and cognitive function has been described in
other studies [9,10,19] and further suggests that tremor likely results from dysfunction of neu-
ral circuits and neurochemical systems that may be distinct from those that underlie cognitive
function. In contrast, associations between different aspects of visuospatial function
Fig 1. Heat map showing the relationships between cognitive test performance (based on correlation
coefficients) and subscores from the Unified Parkinson’s Disease Rating Scale (UPDRS) motor
scales.Green denotes a significant negative correlation, red denotes a significant positive correlation and
black denotes no significant correlation. The intensity of the color reflects the strength of the correlation.
doi:10.1371/journal.pone.0123231.g001
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(performance of RULIT task, conditional associative learning, and spatial working memory)
and posture/balance/gait were significant, suggesting potentially overlapping processes in-
volved in these functions. In a retrospective analysis of established, non-demented PD patients,
it was noted that patients with MCI had higher postural instability and gait disorder subscale
scores than cognitively intact patients, suggesting and association of these motor symptoms
with increased cognitive dysfunction [20]. Similarly, early stage, drug naïve PD patients were
found to have associations between visuospatial function (and episodic memory) and severity
of axial symptoms [13]. The findings that these associations span different stages of the disease
and are found in early, unmedicated patients as well as in more advanced patients take on par-
ticular significance since others have reported that patients whose motor symptoms are promi-
nently characterized by posture and gait disturbances, motor symptoms that are traditionally
less responsive to dopaminergic therapy, have increased risk for developing dementia [18,21].
The current study has several potential limitations. The motor function data reported in
this paper was the result of clinical assessments and thus relied on clinical judgement of the in-
vestigators rather than objective assessments of motor function. However, as described previ-
ously by us [22], subjects were observed by two independent raters to improve the precision of
this measure. There is also the possibility that some of the neuropsychological measures may
have been directly affected by impaired motor function. We think motor disability was unlikely
a significant contributing factor to the neuropsychological test results since most tests relied on
verbal responses, had no particular timing component that would adversely impact perfor-
mance, or had built in controls for motor performance. Since this study utilized subjects al-
ready receiving anti-PD medications, including levodopa, results obtained during a practically
defined “off” period may have been complicated by any potential long duration response to
levodopa, and such effects could have contributed to the current findings. However, to the best
of our knowledge, long duration effects of levodopa on cognitive function, as assessed in this
study, have not been reported. Lastly, because of the number of comparisons made, some of
the findings reported here may be not be true associations. We did not correct for multiple
comparisons as we wanted to minimize the chance of falsely excluding potentially true rela-
tionships, although possibly at the expense of reporting an occasional spurious association.
However, we believe that findings related to the lack of any associations of cognitive data with
tremor and associations of cognitive data with posture/balance/gait in particular are true as
multiple associations within a given cognitive test were found and were all in the same direc-
tion. Nevertheless, additional studies may be warranted to confirm our results.
Conclusions
Our findings suggest that in PD patients who have advanced to requiring anti-PD therapies,
there are salient associations between axial signs and different aspects of cognition, and partic-
ularly with visuospatial learning and memory suggesting involvement of similar circuits in
these functions. Associations between executive functions and bradykinesia also suggest in-
volvement similar circuits in these functions. Age appeared to be the demographic factor most
associated with neuropsychological test performance. The more information we gather about
possible relationships between demographic factors, cognition, and motor function, the better
we might be able to understand the origins of and perhaps predict the course of different cogni-
tive and motor symptoms in PD.
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